Autologous Stem Cell Transplantation and Maintenance Therapy for Multiple Myeloma
Stopped Study is no longer needed as recent data have answered the primary hypotheses for this study.
Conditions
Interventions
- DRUG: Melphalan
- DRUG: Lenalidomide
Sponsor
University of Virginia